Shermaine Abad

Shermaine Abad

Auto-generated profile, based on publicly available information

Shermaine Abad

ScHARe Fellows Program, NIH AIM–AHEAD Consortium

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2026 in Developmental Cognitive Neuroscience
Verified
Journal Article
Open access
JLJanosch Linkersdörfer
Janosch Linkersdörfer
SBSammy Berman
Sammy Berman
CSCalen Smith
Calen Smith
LZLaura Ziemer
Laura Ziemer
LZLe Zhang
Le Zhang
ADAnders M. Dale
Anders M. Dale
This paper synthesizes ten years of experience from the Adolescent Brain Cognitive DevelopmentSM (ABCD) Study’s Data Analysis, Informatics, & Resource Center (DAIRC), focusing on strategies for the collection, management, and release of data for a large, multi-site, multi-modal longitudinal study. We highlight lessons learned in two major domains: First, we describe the development and ongoing refinement of internal processes, including the design of cognitively ergonomic electronic data capture instruments, improvements to data ingestion and quality control procedures, and the development of recruitment, retention, and protocol completeness metrics as well as related tools to support results-based accountability efforts. We further describe how structure and adaptability have enhanced the DAIRC’s efficiency and resilience in the face of challenges such as the COVID-19 pandemic, participant mobility, and staff turnover at data collection sites. Second, we detail the development of standards for data curation and organization, as well as a sharing infrastructure that supports open science, transparency, and reproducibility, with the goal to lower barriers to scientific use of the ABCD data resource, facilitate collaboration, and promote best practices. We conclude by considering how these strategies can inform future multi-site longitudinal studies, providing a framework for scalable and sustainable data center operations.

7 October 2026 in Machine Learning: Health
Verified
Journal Article
Open access
CFC Flynn
C Flynn
SAS Abad
S Abad
BWB Wooton
B Wooton
CJChad Jansen
Chad Jansen
BJB Johnson
B Johnson
HTHelen Turner
Helen Turner
Background: Substance use disorder is a pressing US public health crisis, with 48.7 million people reporting past-year substance use and over 100 000 overdose deaths in 2022. Building on a growing body of machine learning research using the SAMHSA treatment episode Data set—discharges (TEDS-D), this study introduces frequency of use at discharge as an outcome variable and the inclusion of U.S. state as a predictor. Research Design and Methods: First, reason for discharge was evaluated as a dependent variable and compared to frequency of use at discharge. Utilizing 2411 351 completed treatment episodes from TEDS-D 2015–2019, a categorical boosting model was employed to predict frequency of substance use at discharge using 62 predictor variables. Shapley additive explanations (SHAP) calculated global feature importance and decomposed individual predictions. State-level models were compared to the national model using rank-biased overlap (RBO), with a Hawai’i case study demonstrating state-level decision support. Results: Although treatment completion yielded higher rates of no use at discharge than dropout (45% vs 28%), 25% of completed episodes reported active substance use, 9% reported homelessness, and 50% reported unemployment at discharge. The model demonstrated strong predictive performance (AUC = 0.96, sensitivity = 0.85, specificity = 0.95). Treatment and geographic factors outweighed patient attributes, with frequency of use at admission, U.S state of treatment, length of stay, and service type as the four most important features. Among all service types, long-term residential rehabilitation was associated with the lowest SHAP values and predicted probability of substance use at discharge. State-stratified models showed moderate feature importance consistency (mean RBO = 0.59, range: 0.30–0.73). The Hawai’i case study identified elevated probability of use at discharge for younger clients and revealed substantial underreporting of long-term residential and therapeutic community treatment modalities in federal data. Discussion and Implications: State-level variability in treatment outcomes reflects systemic inconsistencies in policy, reporting, and service access that complicate national benchmarking and may obscure the true drivers of patient recovery. Explainable ML provides actionable insights for tailoring treatment and informing data-driven policy to improve outcomes.

11 September 2025
Verified
Dataset
Closed access
LZLe Zhang
Le Zhang
JLJanosch Linkersdoerfer
Janosch Linkersdoerfer
OCOlivier Celhay
Olivier Celhay
BDBiplabendu Das
Biplabendu Das
SBSammy Berman
Sammy Berman
SAShermaine Abad
Shermaine Abad
Provides functions to compute summary scores (besides proprietary ones) reported in the tabulated data resource that is released by the Adolescent Brain Cognitive Development (ABCD) study. Feldstein Ewing and Luciana (2018) .